| WHO's new end TB strategy M Uplekar, D Weil, K Lonnroth, E Jaramillo, C Lienhardt, HM Dias, ... The Lancet 385 (9979), 1799-1801, 2015 | 1316 | 2015 |
| Tuberculosis control and elimination 2010–50: cure, care, and social development K Lönnroth, KG Castro, JM Chakaya, LS Chauhan, K Floyd, P Glaziou, ... The lancet 375 (9728), 1814-1829, 2010 | 1166 | 2010 |
| Towards tuberculosis elimination: an action framework for low-incidence countries K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ... European Respiratory Journal 45 (4), 928-952, 2015 | 875 | 2015 |
| Global epidemiology of tuberculosis P Glaziou, D Falzon, K Floyd, M Raviglione Seminars in respiratory and critical care medicine 34 (01), 003-016, 2013 | 601 | 2013 |
| Prospects for tuberculosis elimination C Dye, P Glaziou, K Floyd, M Raviglione Annual review of public health 34 (1), 271-286, 2013 | 467 | 2013 |
| The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era K Floyd, P Glaziou, A Zumla, M Raviglione The Lancet Respiratory Medicine 6 (4), 299-314, 2018 | 450 | 2018 |
| Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts BJ Marais, K Lönnroth, SD Lawn, GB Migliori, P Mwaba, P Glaziou, ... The Lancet infectious diseases 13 (5), 436-448, 2013 | 377 | 2013 |
| Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010 M Zignol, W Gemert, D Falzon, C Sismanidis, P Glaziou, K Floyd, ... Bulletin of the world Health Organization 90, 111-119, 2012 | 373 | 2012 |
| Global tuberculosis control: lessons learnt and future prospects C Lienhardt, P Glaziou, M Uplekar, K Lönnroth, H Getahun, M Raviglione Nature Reviews Microbiology 10 (6), 407-416, 2012 | 349 | 2012 |
| Global epidemiology of tuberculosis P Glaziou, K Floyd, MC Raviglione Seminars in respiratory and critical care medicine 39 (03), 271-285, 2018 | 346 | 2018 |
| Global epidemiology of tuberculosis and progress toward achieving global targets—2017 A MacNeil MMWR. Morbidity and mortality weekly report 68, 2019 | 272 | 2019 |
| Measuring tuberculosis burden, trends, and the impact of control programmes C Dye, A Bassili, AL Bierrenbach, JF Broekmans, VK Chadha, P Glaziou, ... The Lancet infectious diseases 8 (4), 233-243, 2008 | 271 | 2008 |
| Global epidemiology of tuberculosis and progress toward meeting global targets—worldwide, 2018 A MacNeil MMWR. Morbidity and mortality weekly report 69, 2020 | 232 | 2020 |
| National tuberculosis prevalence surveys in Asia, 1990–2012: an overview of results and lessons learned I Onozaki, I Law, C Sismanidis, M Zignol, P Glaziou, K Floyd Tropical Medicine & International Health 20 (9), 1128-1145, 2015 | 206 | 2015 |
| Comparison of ivermectin and benzyl benzoate for treatment of scabies. P Glaziou, JL Cartel, P Alzieu, C Briot, JP Moulia-Pelat, PM Martin Tropical Medicine and Parasitology: Official Organ of Deutsche …, 1993 | 190 | 1993 |
| Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020 P Glaziou MedRxiv, 2020.04. 28.20079582, 2020 | 185 | 2020 |
| The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1 DJ Carter, P Glaziou, K Lönnroth, A Siroka, K Floyd, D Weil, M Raviglione, ... The Lancet Global Health 6 (5), e514-e522, 2018 | 184 | 2018 |
| Impact and cost-effectiveness of new tuberculosis vaccines in low-and middle-income countries GM Knight, UK Griffiths, T Sumner, YV Laurence, A Gheorghe, A Vassall, ... Proceedings of the National Academy of Sciences 111 (43), 15520-15525, 2014 | 183 | 2014 |
| Global burden and epidemiology of tuberculosis P Glaziou, K Floyd, M Raviglione Clinics in chest medicine 30 (4), 621-636, 2009 | 174 | 2009 |
| Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study M Zignol, AM Cabibbe, AS Dean, P Glaziou, N Alikhanova, C Ama, ... The Lancet Infectious Diseases 18 (6), 675-683, 2018 | 161 | 2018 |
Mario RaviglioneProfessor of Global Health, University of Milan, Italy在 unimi.it 的电子邮件经过验证
